Shalby is currently trading at Rs. 163.40, up by 1.35 points or 0.83% from its previous closing of Rs. 162.05 on the BSE.
The scrip opened at Rs. 163.50 and has touched a high and low of Rs. 165.00 and Rs. 163.10 respectively. So far 673 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 274.00 on 09-Jan-2018 and a 52 week low of Rs. 160.55 on 25-Jun-2018.
Last one week high and low of the scrip stood at Rs. 174.90 and Rs. 161.15 respectively. The current market cap of the company is Rs. 1761.64 crore.
The promoters holding in the company stood at 79.41%, while Institutions and Non-Institutions held 6.72% and 13.86% respectively.
Shalby Hospitals has launched a Centre for Liver Disease and Transplant in its SG Highway, Ahmedabad facility. The hospital now has the expertise for all types of liver transplants including deceased donor liver transplants, living donor liver transplants, for adults as well as children, elective as well as emergency.
Shalby is a chain of Multi-specialty tertiary care hospitals based out of Ahmedabad. It has combined bed strength of more than 700 beds with its multispecialty hospitals across Gujarat and Goa. To cater to specific needs of International Patients, the company has a dedicated International Patients Cell providing round the clock services to International Patients.
